Cite
HARVARD Citation
Gladman, D. et al. (n.d.). SAT0448 Apremilast treatment and long-term (up to 156 weeks) improvements in dactylitis and enthesitis in patients with psoriatic arthritis: analysis of a large database of the phase iii clinical development program. Annals of the rheumatic diseases. p. 942. [Online].